Evaluation of Venezuelan Equine Encephalitis (VEE) replicon-based Outer surface protein A (OspA) vaccines in a tick challenge mouse model of Lyme disease

By Gipson C.L.   Davis N.L.   Johnston R.E.   de Silva A.M.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3875-3884

Elsevier

Access to resources Recommend Favorite

Perspectives on FIV vaccine development

By Elyar J.S.   Tellier M.C.   Soos J.M.   Yamamoto J.K.  

Vaccine, Vol. 15, Iss. 12, 1997-08 ,pp. : 1437-1444

Elsevier

Access to resources Recommend Favorite

Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza

By Ze C.   Sahashi Y.   Matsuo K.   Asanuma H.   Takahashi H.   Iwasaki T.   Suzuki Y.   Aizawa C.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 16, Iss. 16, 1998-10 ,pp. : 1544-1549

Elsevier

Access to resources Recommend Favorite

Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: vector design strategies for improved vaccine efficacy

By Caley I.J.   Betts M.R.   Davis N.L.   Swanstrom R.   Frelinger J.A.   Johnston R.E.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 3124-3135

Elsevier

Access to resources Recommend Favorite

Induction of protective immune responses against Venezuelan equine encephalitis (VEE) virus aerosol challenge with microencapsulated VEE virus vaccine

By Greenway T.E.   Eldrige J.H.   Ludwig G.   Staas J.K.   Smith J.F.   Gilley R.M.   Michalek S.M.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1314-1323

Elsevier

Access to resources Recommend Favorite